Pilot clinical trial of the combination of hydroxyurea and didanosine in HIV-1 infected individuals

被引：20

作者：

Biron, F

Lucht, F

Peyramond, D

Fresard, A

Vallet, T

Nugier, F

Grange, J

Malley, S

HamediSangsari, F

Vila, J

机构：

[1] CO DEV AGUETTANT SA, F-69353 LYON 07, FRANCE

[2] INSERM, LYON, FRANCE

[3] HOP CROIX ROUSSE, SERV MALAD INFECT & TROP, F-69317 LYON, FRANCE

[4] HOP BELLEVUE, SERV MALAD INFECT & TROP, ST ETIENNE, FRANCE

来源：

ANTIVIRAL RESEARCH | 1996年 / 29卷 / 01期

关键词：

HIV-1; hydroxyurea; didanosine;

D O I：

10.1016/0166-3542(95)00931-0

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：111 / 113

页数：3

相关论文

共 6 条

[1] BIRON F, 1995, J ACQ IMMUN DEF SYND, V10, P36
[2] DONEHOWER RC, 1992, SEMIN ONCOL, V19, P11
[3] HYDROXYUREA AS AN INHIBITOR OF HUMAN IMMUNODEFICIENCY VIRUS-TYPE-1 REPLICATION
LORI, F
MALYKH, A
CARA, A
SUN, D
WEINSTEIN, JN
LISZIEWICZ, J
GALLO, RC
[J]. SCIENCE, 1994, 266 (5186) : 801 - 805
[4] SYNERGISTIC ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 EFFECT OF HYDROXAMATE COMPOUNDS WITH 2',3'-DIDEOXYINOSINE IN INFECTED RESTING HUMAN-LYMPHOCYTES
MALLEY, SD
GRANGE, JM
HAMEDISANGSARI, F
VILA, JR
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (23) : 11017 - 11021
[5] SUPPRESSION OF HIV PRODUCTION IN RESTING LYMPHOCYTES BY COMBINING DIDANOSINE AND HYDROXAMATE COMPOUNDS
MALLEY, SD
GRANGE, JM
HAMEDISANGSARI, F
VILA, JR
[J]. LANCET, 1994, 343 (8908) : 1292 - 1292
[6] COMPARATIVE-ASSESSMENT OF QUANTITATIVE HIV VIREMIA ASSAYS
ROUZIOUX, C
PUEL, J
AGUT, H
BRUNVEZINET, F
FERCHAL, F
TAMALET, C
DESCAMPS, P
FLEURY, H
[J]. AIDS, 1992, 6 (04) : 373 - 377